FIELD: organic chemistry, biochemistry, medicine, pharmacy.
SUBSTANCE: invention relates to N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazole carboxamide of the formula: 
and to its pharmaceutically acceptable salts. Also, invention describes a pharmaceutical composition inhibiting activity of protein-tyrosine kinases and comprising the indicated compound, a method for treatment of disorders associated with protein-tyrosine kinases, such as an immune disorder, and oncology disease, and a method for cancer treatment.
EFFECT: valuable biochemical and medicinal properties of compounds and composition.
5 cl, 2 tbl, 581 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF PYRROLO[2,3-D]PYRIMIDINES, PHARMACEUTICAL COMPOSITION, PYRROLO[2,3-D]PYRIMIDINES, DERIVATIVES OF PYRROLE | 1993 |
|
RU2124015C1 |
| DIPEPTIDYL PEPTIDASE IV INHIBITORS BASED ON CONDENSED CYCLOPROPYLPYRROLIDINES AND METHOD FOR THEIR USING | 2001 |
|
RU2286986C2 |
| DERIVATIVES OF PYRAZOLE AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 1993 |
|
RU2142946C1 |
| PYRAZOLO- AND PYRROLOPYRIDINES | 1995 |
|
RU2135498C1 |
| 1,4-SUBSTITUTED PIPERAZINES OR 4-ALKYLIDENYL PIPERIDINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD FOR TREATMENT | 2000 |
|
RU2241707C2 |
| O-ARYLGLUCOSIDE INHIBITORS OF SGLT2 AND METHOD FOR THEIR USING | 2001 |
|
RU2269540C2 |
| CYCLIC INHIBITORS OF PROTEIN-TYROSINE KINASE | 2000 |
|
RU2312860C2 |
| SUBSTITUTED DIALKYL (OXIDE)-Λ-SULFANILIDENE NICOTINAMIDE DERIVATIVES AS KINASE INHIBITORS | 2014 |
|
RU2711749C2 |
| PYRAZOLOPYRIMIDINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1993 |
|
RU2124016C1 |
| SERIN / TREONIN KINASE INHIBITORS FOR TREATING OF HYPEROPLIFERATIVE DISEASES | 2013 |
|
RU2644947C2 |
